(Boursier.com) — AB Science SA will hold a virtual conference, on February 28, on masitinib’s application for registration in the treatment of amyotrophic lateral sclerosis (ALS) in Canada under the NOC/c procedure, as well as on its clinical program in all indications.
Alain Moussy (co-founder and president of AB Science), Laurent Guy (financial director of AB Science) and Olivier Hermine (MD, PhD, president of the scientific committee of AB Science and member of the Academy of Sciences) will participate at this virtual conference which will be held from 6 p.m. to 7:30 p.m. CET (12 p.m. to 1:30 p.m. ET).
This conference will be followed by a question and answer session with the management of AB Science.
©2022 Boursier.com